BBIO

Insider trade Sale by Kumar Neil (Chief Executive Officer)

6d ago

Insider trade Sale by Trimarchi Thomas (President and CFO)

13d ago

Insider trade Sale by Scott Randal W.

13d ago

News Ionis, Alnylam, BioMarin up as Citi starts at Buy on catalyst and growth outlook

13d ago

News BridgeBio Nears 52-Week High On Strong Dwarfism Trial Data, Plans FDA Filing In 2026

14d ago

News Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk

14d ago

News BridgeBio Pharma Seeks Partner To Develop Gene Therapy For Inherited Condition

14d ago

SEC filing BBIO Submits NDA, 76% Achieve Calcium Targets vs 4% SOC, Fast‑Track, Launch 2027

19d ago

Insider trade Sale by Neil Kumar (Chief Executive Officer)

21d ago

Insider trade Sale by Neil Kumar (Chief Executive Officer)

21d ago

News BridgeBio falls despite new Attruby data

21d ago

SEC filing BBIO Enters $500M At-The-Market Offering with Goldman Sachs, Leerink Partners, Terminates Prior Agreement

25d ago

Insider trade Sale by Maricel Apuli (Chief Accounting Officer)

28d ago

News BridgeBio gains after settlement in Pfizer Vyndamax patent dispute

35d ago

Insider trade Sale by Neil Kumar (Chief Executive Officer)

49d ago

Insider trade Sale by Neil Kumar (Chief Executive Officer)

77d ago

Insider trade Sale by Hannah Valantine

81d ago

News BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz

83d ago

Insider trade Sale by Andrea Ellis

87d ago

Insider trade Sale by Hannah Valantine

90d ago

Insider trade Sale by Maricel Apuli (Chief Accounting Officer)

94d ago

Insider trade Sale by Neil Kumar (Chief Executive Officer)

98d ago

News Is Carvana Stock a Buy After Crushing Q4 Expectations? - Zacks Investment Research

103d ago

Insider trade Sale by Randal W. Scott

103d ago

Insider trade Sale by Neil Kumar (Chief Executive Officer)

104d ago